The impact of exposure to cannabinoids in adolescence: Insights from animal models

Biological Psychiatry

Volumn 79, Issue 7, 2016, Pages 578-585

  Rubino, Tiziana ^a   Parolaro, Daniela ^a  

^a UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

Adolescence; Cannabinoids; Endocannabinoid system; GABA; Glutamate

Indexed keywords

CANNABINOID; ENDOCANNABINOID; 4 AMINOBUTYRIC ACID;

ADOLESCENT; ADULTHOOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY DISORDER; CANNABIS USE; COGNITION; DEPRESSION; DISEASE ASSOCIATION; ENVIRONMENTAL EXPOSURE; LEARNING DISORDER; LONG TERM MEMORY; MEMORY DISORDER; NEUROBIOLOGY; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PSYCHOSIS; REVIEW; RISK FACTOR; SCHIZOPHRENIA; SOCIAL BEHAVIOR; ANIMAL; BRAIN; CANNABIS ADDICTION; DISEASE MODEL; DRUG EFFECTS; HUMAN; LEARNING; MEMORY; METABOLISM; MOUSE; PATHOPHYSIOLOGY; RAT;

ADOLESCENT; ANIMALS; BRAIN; CANNABINOIDS; COGNITION; DISEASE MODELS, ANIMAL; ENDOCANNABINOIDS; GAMMA-AMINOBUTYRIC ACID; HUMANS; LEARNING; MARIJUANA ABUSE; MEMORY; MICE; PSYCHOSES, SUBSTANCE-INDUCED; RATS;

EID: 84940825317     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2015.07.024     Document Type: Review

References (97)

1. Colver A, Longwell S (2013): New understanding of adolescent brain development: Relevance to transitional healthcare for young people with long term conditions. Arch Dis Child 98:902-907.
2. Houston SM, Lebel C, Katzir T, Manis FR, Kan E, Rodriguez GG, et al. (2014): Reading skill and structural brain development. Neuroreport 25:347-352.
3. Luciana M (2013): Adolescent brain development in normality and psychopathology. Dev Psychopathol 25:1325-1345.
4. Sturman DA, Moghaddam B (2011): The neurobiology of adolescence: Changes in brain architecture, functional dynamics, and behavioral tendencies. Neurosci Biobehav Rev 35:1704-1712.
5. Giedd JN, Blumenthal J, Jeffries NO, Castellanos FX, Liu H, Zijdenbos A, et al. (1999): Brain development during childhood and adolescence: A longitudinal MRI study. Nat Neurosci 2:861-863.
6. Sowell ER, Thompson PM, Holmes CJ, Jernigan TL, Toga AW (1999): In vivo evidence for post-adolescent brain maturation in frontal and striatal regions. Nat Neurosci 2:859-861.
7. Sowell ER, Thompson PM, Holmes CJ, Batth R, Jernigan TL, Toga AW (1999): Localizing age-related changes in brain structure between childhood and adolescence using statistical parametric mapping. Neuroimage 9:587-597.
8. Sowell ER, Thompson PM, Toga AW (2004): Mapping changes in the human cortex throughout the span of life. Neuroscientist 10:372-392.
9. Gogtay N, Giedd JN, Lusk L, Hayashi KM, Greenstein D, Vaituzis AC, et al. (2004): Dynamic mapping of human cortical development during childhood through early adulthood. Proc Natl Acad Sci U S A 101: 8174-8179.
10. Bourgeois JP, Goldman-Rakic PS, Rakic P (1994): Synaptogenesis in the prefrontal cortex of rhesus monkeys. Cereb Cortex 4:78-96.
11. Huttenlocher PR (1990): Morphometric study of human cerebral cortex development. Neuropsychologia 28:517-527.
12. Paus T (2010): Growth of white matter in the adolescent brain: Myelin or axon? Brain Cogn 72:26-35.
13. Cunningham MG, Bhattacharyya S, Benes FM (2002): Amygdalocortical sprouting continues into early adulthood: Implications for the development of normal and abnormal function during adolescence. J Comp Neurol 453:116-130.
14. Asato MR, Terwilliger R, Woo J, Luna B (2010): White matter development in adolescence: A DTI study. Cereb Cortex 20: 2122-2131.
15. Simon NW, Moghaddam B (2015): Neural processing of reward in adolescent rodents. Dev Cogn Neurosci 11:145-154.
16. Andersen SL, Thompson AT, Rutstein M, Hostetter JC, Teicher MH (2000): Dopamine receptor pruning in prefrontal cortex during the periadolescent period in rats. Synapse 37:167-169.
17. Tarazi FI, Tomasini EC, Baldessarini RJ (1998): Postnatal development of dopamine D4-like receptors in rat forebrain regions: Comparison with D2-like receptors. Brain Res Dev Brain Res 110:227-233.
18. McCutcheon JE, Marinelli M (2009): Age matters. Eur J Neurosci 29: 997-1014.
19. Hedner T, Iversen K, Lundborg P (1984): Central GABA mechanisms during postnatal development in the rat: Neurochemical characteristics. J Neural Transm 59:105-118.
20. Zamberletti E, Beggiato S, Steardo L Jr, Prini P, Antonelli T, Ferraro L, et al. (2014): Alterations of prefrontal cortex GABAergic transmission in the complex psychotic-like phenotype induced by adolescent delta- 9-tetrahydrocannabinol exposure in rats. Neurobiol Dis 63:35-47.
21. Kilb W (2012): Development of the GABAergic system from birth to adolescence. Neuroscientist 18:613-630.
22. Hoftman GD, Lewis DA (2011): Postnatal developmental trajectories of neural circuits in the primate prefrontal cortex: Identifying sensitive periods for vulnerability to schizophrenia. Schizophr Bull 37:493-503.
23. Rubino T, Prini P, Piscitelli F, Zamberletti E, Trusel M, Melis M, et al. (2015): Adolescent exposure to THC in female rats disrupts developmental changes in the prefrontal cortex. Neurobiol Dis 73:60-69.
24. Wang HX, Gao WJ (2009): Cell type-specific development of NMDA receptors in the interneurons of rat prefrontal cortex. Neuropsychopharmacology 34:2028-2040.
25. Díaz-Alonso J, Guzmán M, Galve-Roperh I (2012): Endocannabinoids via CB1 receptors act as neurogenic niche cues during cortical development. Philos Trans R Soc Lond B Biol Sci 367:3229-3241.
26. Maccarrone M, Guzmán M, Mackie K, Doherty P, Harkany T (2014): Programming of neural cells by (endo)cannabinoids: From physiological rules to emerging therapies. Nat Rev Neurosci 15:786-801.
27. Belue RC, Howlett AC, Westlake TM, Hutchings DE (1995): The ontogeny of cannabinoid receptors in the brain of postnatal and aging rats. Neurotoxicol Teratol 17:25-30.
28. Verdurand M, Nguyen V, Stark D, Zahra D, Gregoire MC, Greguric I, et al. (2011): Comparison of cannabinoid CB(1) receptor binding in adolescent and adult rats: A positron emission tomography study using [F]MK-9470. Int J Mol Imaging 2011:548123.
29. Ellgren M, Artmann A, Tkalych O, Gupta A, Hansen HS, Hansen SH, et al. (2008): Dynamic changes of the endogenous cannabinoid and opioid mesocorticolimbic systems during adolescence: THC effects. Eur Neuropsychopharmacol 18:826-834.
30. Eggan SM, Mizoguchi Y, Stoyak SR, Lewis DA (2010): Development of cannabinoid 1 receptor protein and messenger RNA in monkey dorsolateral prefrontal cortex. Cereb Cortex 20:1164-1174.
31. Lee TT, Hill MN, Hillard CJ, Gorzalka BB (2013): Temporal changes in N-acylethanolamine content and metabolism throughout the periadolescent period. Synapse 67:4-10.
32. Leweke FM, Schneider M (2011): Chronic pubertal cannabinoid treatment as a behavioural model for aspects of schizophrenia: Effects of the atypical antipsychotic quetiapine. Int J Neuropsychopharmacol 14:43-51.
33. O'Shea M, McGregor IS, Mallet PE (2006): Repeated cannabinoid exposure during perinatal, adolescent or early adult ages produces similar longlasting deficits in object recognition and reduced social interaction in rats. J Psychopharmacol 20:611-621.
34. O'Shea M, Singh ME, McGregor IS, Mallet PE (2004): Chronic cannabinoid exposure produces lasting memory impairment and increased anxiety in adolescent but not adult rats. J Psychopharmacol 18:502-508.
35. Quinn HR, Matsumoto I, Callaghan PD, Long LE, Arnold JC, Gunasekaran N, et al. (2008): Adolescent rats find repeated delta(9)- THC less aversive than adult rats but display greater residual cognitive deficits and changes in hippocampal protein expression following exposure. Neuropsychopharmacology 33:1113-1126.
36. Realini N, Viganò D, Guidali C, Zamberletti E, Rubino T, Parolaro D (2011): Chronic URB597 treatment at adulthood reverted most depressive-like symptoms induced by adolescent exposure to THC in female rats. Neuropharmacology 60:235-243.
37. Rubino T, Viganò D, Realini N, Guidali C, Braida D, Capurro V, et al. (2008): Chronic delta(9)-tetrahydrocannabinol during adolescence provokes sex-dependent changes in the emotional profile in adult rats: Behavioral and biochemical correlates. Neuropsychopharmacology 33:2760-2771.
38. Higuera-Matas A, Botreau F, Miguéns M, Del Olmo N, Borcel E, Pérez-Alvarez L, et al. (2009): Chronic periadolescent cannabinoid treatment enhances adult hippocampal PSA-NCAM expression in male Wistar rats but only has marginal effects on anxiety, learning and memory. Pharmacol Biochem Behav 93:482-490.
39. Bambico FR, Nguyen NT, Katz N, Gobbi G (2010): Chronic exposure to cannabinoids during adolescence but not during adulthood impairs emotional behaviour and monoaminergic neurotransmission. Neurobiol Dis 37:641-655.
40. Mateos B, Borcel E, Loriga R, Luesu W, Bini V, Llorente R, et al. (2011): Adolescent exposure to nicotine and/or the cannabinoid agonist CP 55, 940 induces gender-dependent long-lasting memory impairments and changes in brain nicotinic and CB(1) cannabinoid receptors. J Psychopharmacol 25:1676-1690.
41. Bortolato M, Bini V, Frau R, Devoto P, Pardu A, Fan Y, et al. (2014): Juvenile cannabinoid treatment induces frontostriatal gliogenesis in Lewis rats. Eur Neuropsychopharmacol 24:974-985.
42. Cadoni C, Simola N, Espa E, Fenu S, Di Chiara G (2015): Strain dependence of adolescent Cannabis influence on heroin reward and mesolimbic dopamine transmission in adult Lewis and Fischer 344 rats. Addict Biol 20:132-142.
43. Biscaia M, Marín S, Fernández B, Marco EM, Rubio M, Guaza C, et al. (2003): Chronic treatment with CP 55, 940 during the peri-adolescent period differentially affects the behavioural responses of male and female rats in adulthood. Psychopharmacology 170:301-308.
44. Wegener N, Koch M (2009): Behavioural disturbances and altered Fos protein expression in adult rats after chronic pubertal cannabinoid treatment. Brain Res 1253:81-91.
45. Llorente-Berzal A, Puighermanal E, Burokas A, Ozaita A, Maldonado R, Marco EM, et al. (2013): Sex-dependent psychoneuroendocrine effects of THC and MDMA in an animal model of adolescent drug consumption. PLoS One 8:e78386.
46. Rubino T, Realini N, Castiglioni C, Guidali C, Viganó D, Marras E, et al. (2008): Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex. Cereb Cortex 18:1292-1301.
47. Ruehle S, Rey AA, Remmers F, Lutz B (2012): The endocannabinoid system in anxiety, fear memory and habituation. J Psychopharmacol 26:23-39.
48. Chadwick B, Saylor AJ, López HH (2011): Adolescent cannabinoid exposure attenuates adult female sexual motivation but does not alter adulthood CB1R expression or estrous cyclicity. Pharmacol Biochem Behav 100:157-164.
49. Abush H, Akirav I (2012): Short- and long-term cognitive effects of chronic cannabinoids administration in late-adolescence rats. PLoS One 7:e31731.
50. Renard J, Krebs MO, Jay TM, Le Pen G (2013): Long-term cognitive impairments induced by chronic cannabinoid exposure during adolescence in rats: A strain comparison. Psychopharmacology (Berl) 225:781-790.
51. Schneider M, Koch M (2003): Chronic pubertal, but not adult chronic cannabinoid treatment impairs sensorimotor gating, recognition memory, and the performance in a progressive ratio task in adult rats. Neuropsychopharmacology 28:1760-1769.
52. Rubino T, Realini N, Braida D, Alberio T, Capurro V, Viganò D, et al. (2009): The depressive phenotype induced in adult female rats by adolescent exposure to THC is associated with cognitive impairment and altered neuroplasticity in the prefrontal cortex. Neurotox Res 15: 291-302.
53. Rubino T, Realini N, Braida D, Guidi S, Capurro V, Viganò D, et al. (2009): Changes in hippocampal morphology and neuroplasticity induced by adolescent THC treatment are associated with cognitive impairment in adulthood. Hippocampus 19:763-772.
54. Verrico CD, Gu H, Peterson ML, Sampson AR, Lewis DA (2014): Repeated Δ9-tetrahydrocannabinol exposure in adolescent monkeys: Persistent effects selective for spatial working memory. Am J Psychiatry 171:416-425.
55. Gomes FV, Guimarães FS, Grace AA (2014): Effects of pubertal cannabinoid administration on attentional set-shifting and dopaminergic hyper-responsivity in a developmental disruption model of schizophrenia. Int J Neuropsychopharmacol 18(2).
56. Cha YM, Jones KH, Kuhn CM, Wilson WA, Swartzwelder HS (2007): Sex differences in the effects of delta9-tetrahydrocannabinol on spatial learning in adolescent and adult rats. Behav Pharmacol 18: 563-569.
57. Geyer MA (2008): Developing translational animal models for symptoms of schizophrenia or bipolar mania. Neurotox Res 14:71-78.
58. Gleason KA, Birnbaum SG, Shukla A, Ghose S (2012): Susceptibility of the adolescent brain to cannabinoids: Long-term hippocampal effects and relevance to schizophrenia. Transl Psychiatry 2:e199.
59. Llorente-Berzal A, Fuentes S, Gagliano H, López-Gallardo M, Armario A, Viveros MP, Nadal R (2011): Sex-dependent effects of maternal deprivation and adolescent cannabinoid treatment on adult rat behaviour. Addict Biol 16:624-637.
60. O'Tuathaigh CM, Clarke G, Walsh J, Desbonnet L, Petit E, O'Leary C, et al. (2012): Genetic vs. pharmacological inactivation of COMT influences cannabinoid-induced expression of schizophrenia-related phenotypes. Int J Neuropsychopharmacol 15:1331-1342.
61. Klug M, van den Buuse M (2013): An investigation into "two hit" effects of BDNF deficiency and young-adult cannabinoid receptor stimulation on prepulse inhibition regulation and memory in mice. Front Behav Neurosci 7:149.
62. Bayer TA, Falkai P, Maier W (1999): Genetic and non-genetic vulnerability factors in schizophrenia: The basis of the "two hit hypothesis.". J Psychiatr Res 33:543-548.
63. Maynard TM, Sikich L, Lieberman JA, LaMantia AS (2001): Neural development, cell-cell signaling, and the "two-hit" hypothesis of schizophrenia. Schizophr Bull 27:457-476.
64. McGrath JJ, Féron FP, Burne TH, Mackay-Sim A, Eyles DW (2003): The neurodevelopmental hypothesis of schizophrenia: A review of recent developments. Ann Med 35:86-93.
65. Van Os J, Bak M, Hanssen M, Bijl RV, de Graaf R, Verdoux H (2002): Cannabis use and psychosis: A longitudinal population-based study. Am J Epidemiol 156:319-327.
66. Henquet C, Di Forti M, Morrison P, Kuepper R, Murray RM (2008): Gene-environment interplay between cannabis and psychosis. Schizophr Bull 34:1111-1121.
67. Gururajan A, Manning EE, Klug M, van den Buuse M (2012): Drugs of abuse and increased risk of psychosis development. Aust N Z J Psychiatry 46:1120-1135.
68. O'Tuathaigh CM, Hryniewiecka M, Behan A, Tighe O, Coughlan C, Desbonnet L, et al. (2010): Chronic adolescent exposure to Δ-9- tetrahydrocannabinol in COMT mutant mice: Impact on psychosisrelated and other phenotypes. Neuropsychopharmacology 35: 2262-2273.
69. Caspi A, Moffitt TE, Cannon M, McClay J, Murray R, Harrington H, et al. (2005): Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol- O-methyltransferase gene: Longitudinal evidence of a gene X environment interaction. Biol Psychiatry 57:1117-1127.
70. Mei L, Xiong WC (2008): Neuregulin 1 in neural development, synaptic plasticity and schizophrenia. Nat Rev Neurosci 9:437-452.
71. Chong VZ, Thompson M, Beltaifa S, Webster MJ, Law AJ, Weickert CS (2008): Elevated neuregulin-1 and ErbB4 protein in the prefrontal cortex of schizophrenic patients. Schizophr Res 100:270-280.
72. Roussos P, Giakoumaki SG, Adamaki E, Bitsios P (2011): The influence of schizophrenia-related neuregulin-1 polymorphisms on sensorimotor gating in healthy males. Biol Psychiatry 69:479-486.
73. Long LE, Chesworth R, Huang XF, McGregor IS, Arnold JC, Karl T (2013): Transmembrane domain Nrg1 mutant mice show altered susceptibility to the neurobehavioural actions of repeated THC exposure in adolescence. Int J Neuropsychopharmacol 16:163-175.
74. Spencer JR, Darbyshire KM, Boucher AA, Kashem MA, Long LE, McGregor IS, et al. (2013): Novel molecular changes induced by Nrg1 hypomorphism and Nrg1-cannabinoid interaction in adolescence: A hippocampal proteomic study in mice. Front Cell Neurosci 7:15.
75. Decoster J, van Os J, Kenis G, Henquet C, Peuskens J, De Hert M, van Winkel R (2011): Age at onset of psychotic disorder: Cannabis, BDNF Val66Met, and sex-specific models of gene-environment interaction. Am J Med Genet B Neuropsychiatr Genet 156B: 363-369.
76. Schneider M, Koch M (2007): The effect of chronic peripubertal cannabinoid treatment on deficient object recognition memory in rats after neonatal mPFC lesion. Eur Neuropsychopharmacol 17:180-186.
77. Vigano D, Guidali C, Petrosino S, Realini N, Rubino T, Di Marzo V, Parolaro D (2009): Involvement of the endocannabinoid system in phencyclidine-induced cognitive deficits modelling schizophrenia. Int J Neuropsychopharmacol 12:599-614.
78. Malone DT, Taylor DA (2006): The effect of Delta9- tetrahydrocannabinol on sensorimotor gating in socially isolated rats. Behav Brain Res 166:101-109.
79. Zamberletti E, Prini P, Speziali S, Gabaglio M, Solinas M, Parolaro D, Rubino T (2012): Gender-dependent behavioral and biochemical effects of adolescent delta-9-tetrahydrocannabinol in adult maternally deprived rats. Neuroscience 204:245-257.
80. Klug M, van den Buuse M (2012): Chronic cannabinoid treatment during young adulthood induces sex-specific behavioural deficits in maternally separated rats. Behav Brain Res 233:305-313.
81. Burston JJ, Wiley JL, Craig AA, Selley DE, Sim-Selley LJ (2010): Regional enhancement of cannabinoid CB1 receptor desensitization in female adolescent rats following repeated Δ9-tetrahydrocannabinol exposure. Br J Pharmacol 161:103-112.
82. Wiley JL, Burston JJ (2014): Sex differences in Δ(9)-tetrahydrocannabinol metabolism and in vivo pharmacology following acute and repeated dosing in adolescent rats. Neurosci Lett 576:51-55.
83. Rubino T, Parolaro D (2011): Sexually dimorphic effects of cannabinoid compounds on emotion and cognition. Front Behav Neurosci 5:64.
84. Huang GZ, Woolley CS (2012): Estradiol acutely suppresses inhibition in the hippocampus through a sex-specific endocannabinoid and mGluR-dependent mechanism. Neuron 74:801-808.
85. Riebe CJ, Hill MN, Lee TT, Hillard CJ, Gorzalka BB (2010): Estrogenic regulation of limbic cannabinoid receptor binding. Psychoneuroendocrinology 35:1265-1269.
86. Higuera-Matas A, Miguéns M, Coria SM, Assis MA, Borcel E, del Olmo N, et al. (2012): Sex-specific disturbances of the glutamate/GABA balance in the hippocampus of adult rats subjected to adolescent cannabinoid exposure. Neuropharmacology 62:1975-1984.
87. Thomases DR, Cass DK, Tseng KY (2013): Periadolescent exposure to the NMDA receptor antagonist MK-801 impairs the functional maturation of local GABAergic circuits in the adult prefrontal cortex. J Neurosci 33:26-34.
88. Cass DK, Flores-Barrera E, Thomases DR, Vital WF, Caballero A, Tseng KY (2014): CB1 cannabinoid receptor stimulation during adolescence impairs the maturation of GABA function in the adult rat prefrontal cortex. Mol Psychiatry 19:536-543.
89. Uhlhaas PJ, Roux F, Singer W, Haenschel C, Sireteanu R, Rodriguez E (2009): The development of neural synchrony reflects late maturation and restructuring of functional networks in humans. Proc Natl Acad Sci U S A 106:9866-9871.
90. Buzsáki G, Draguhn A (2004): Neuronal oscillations in cortical networks. Science 304:1926-1929.
91. Wang XJ (2010): Neurophysiological and computational principles of cortical rhythms in cognition. Physiol Rev 90:1195-1268.
92. Uhlhaas PJ, Singer W (2010): Abnormal neural oscillations and synchrony in schizophrenia. Nat Rev Neurosci 11:100-113.
93. Gonzalez-Burgos G, Fish KN, Lewis DA (2011): GABA neuron alterations, cortical circuit dysfunction and cognitive deficits in schizophrenia. Neural Plast 2011:723184.
94. Raver SM, Haughwout SP, Keller A (2013): Adolescent cannabinoid exposure permanently suppresses cortical oscillations in adult mice. Neuropsychopharmacology 38:2338-2347.
95. Raver SM, Keller A (2014): Permanent suppression of cortical oscillations in mice after adolescent exposure to cannabinoids: Receptor mechanisms. Neuropharmacology 86:161-173.
96. Selemon LD (2013): A role for synaptic plasticity in the adolescent development of executive function. Transl Psychiatry 3:e238.
97. Carvalho AF, Reyes BA, Ramalhosa F, Sousa N, Van Bockstaele EJ (2014): Repeated administration of a synthetic cannabinoid receptor agonist differentially affects cortical and accumbal neuronal morphology in adolescent and adult rats [published online ahead of print Oct 28]. Brain Struct Funct.